Fighting Zika, Dengue Fever, Malaria, and Chikungunya Worldwide

Share Article

The management team at Renuent Group Worldwide brings breakthrough nano technology directly to the front lines in a direct assault on the Aedes Aegypti at their points of origin.

The management team at Renuent Group Worldwide (http://www.renuent.com) brings breakthrough nano technology directly to the front lines in a direct assault on the Aedes Aegypti at their points of origin. Renuent Group Worldwide's goal is to implement it's proprietary mosquito eradication program, which includes deploying hundreds of trained biosecurity technicians throughout Latin America and the Caribbean. RWG's proven non-toxic methods also help control and manage other mosquito-borne diseases, including Dengue Fever, Malaria, and Chikungunya. The company's corporate ethos is to manage the cycle of larvae at their core.

Renuent Group Worldwide prides itself on being a socially conscious enterprise. It provides employment to local workers, a policy that boosts economic growth and awareness within its partner host countries.

H.M. Patino, Renuent Group Worldwide’s new Director of Global Director of Biosecurity, said in a recent statement to the international press, “Renuent Group Worldwide’s mosquito control and eradication management has proven extremely effective in containing mosquito-borne diseases. Our team of first responders and experienced mosquito control experts provides a first line of defense against mosquito-borne diseases. We are ready to take action immediately.”

About Renuent Group Worldwide

Renuent Group Worldwide provides the tools and manpower to control local mosquito populations. We use eco-responsible, ultra-low toxicity, nonmutagenic technologies to control microbes and insects, in agriculture, commercial, hospitality, institutional, medical, and transportation markets.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Martin Grossman

Martin Grossman
Visit website